

A novel protein risk score created to predict the probability of death in people with heart failure (HF) has shown satisfactory calibration and may assist doctors in better stratifying mortality risk in these patients. Annals of Internal Medicine published the score.
Heart failure is a complex clinical illness that is associated with a high mortality rate. Current risk classification techniques are restricted in their ability to represent the molecular complexity of the HF condition while also demonstrating therapeutic value. Although high-throughput proteomics has the potential to improve risk prediction, its use in clinical practice to assist the management of patients with heart failure is dependent on validation and proof of clinical benefit.
Using a community-based cohort of 7,289 plasma proteins from 1,351 patients with heart condition, researchers from the National Institutes of Health developed and validated a protein risk score to stratify mortality risk in people with heart failure.
For the protein risk score, 38 distinct proteins were chosen from the development cohort. When compared to the clinical model, the protein risk score revealed better calibration, reclassified mortality risk, particularly at the extremes of the risk distribution, and demonstrated improved clinical value.
These findings, according to the researchers, anticipate the clinical relevance of large-scale proteomic assays for precision risk prediction in HF. This tool may assist doctors in identifying candidates for quick drug titration or patients with advanced HF who are at high risk of severe outcomes and should be considered for mechanical circulatory support or transplantation.
For more information: Development and Validation of a Protein Risk Score for Mortality in Heart Failure, Annals of Internal Medicine
more recommended stories
Statins and Depression: No Added Benefit
What Are Statins Used For? Statins.
Azithromycin Resistance Rises After Mass Treatment
Mass drug administration (MDA) of azithromycin.
Generative AI in Health Campaigns: A Game-Changer
Mass media campaigns have long been.
Molecular Stress in Aging Neurons Explained
As the population ages, scientists are.
Higher BMI and Hypothyroidism Risk Study
A major longitudinal study from Canada.
Therapeutic Plasma Exchange Reduces Biological Age
Therapeutic plasma exchange (TPE), especially when.
Childhood Cancer Diagnosis Delays Persist
Delays in childhood cancer diagnosis remain.
Hypothalamic Changes in Eating Disorders Explained
Groundbreaking MRI scans reveal microstructural hypothalamic.
Rapid Blood Test for Rare Diseases Revolutionizes Pediatric Diagnosis
A groundbreaking blood test developed by.
Blood Markers for Teen Depression: A Breakthrough in Early Detection
Mental health professionals and researchers have.
Leave a Comment